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Introduction: Myocardial dysfunction is a well-known complication in septic shock but its characteristics and
frequency remains elusive. Here, we evaluate global longitudinal peak strain (GLPS) of the left ventricle as a
diagnostic and prognostic tool in septic shock.
Methods: Fifty adult patients with septic shock admitted to a general intensive care unit were included.
Transthoracic echocardiography was performed on the first day, and repeated during and after ICU stay. Laboratory
and clinical data and data on outcome were collected daily from admission and up to 7 days, shorter in cases of
death or ICU discharge. The correlation of GLPS to left ventricular systolic and diastolic function parameters, cardiac
biomarkers and clinical data were compared using Spearman’s correlation test and linear regression analysis, and
the ability of GLPS to predict outcome was evaluated using a logistic regression model.
Results: On the day of admission, there was a strong correlation and co-linearity of GLPS to left ventricular ejection
fraction (LVEF), mitral annular motion velocity (é) and to amino-terminal pro-brain natriuretic peptide (NT-proBNP)
(Spearman’s ρ -0.70, −0.53 and 0.54, and R2 0.49, 0.20 and 0.24, respectively). In LVEF and NT-proBNP there was a
significant improvement during the study period (analysis of variance (ANOVA) with repeated measures, p = 0.05
and p < 0.001, respectively), but not in GLPS, which remained unchanged over time (p = 0.10). GLPS did not correlate
to the improvement in clinical characteristics over time, did not differ significantly between survivors and non-survivors
(−17.4 (−20.5-(−13.7)) vs. -14.7 (−19.0 - (−10.6)), p = 0.11), and could not predict mortality.
Conclusions: GLPS is frequently reduced in septic shock patients, alone or in combination with reduced LVEF and/or é.
It correlates with LVEF, é and NT-proBNP, and remains affected over time. GLPS may provide further understanding on
the character of myocardial dysfunction in septic shock.Introduction
Myocardial dysfunction in septic shock was first de-
scribed as a condition of systolic depression despite
normal or high cardiac output, demonstrating reversibility
on remission [1,2]. Since the introduction of echocardiog-
raphy in intensive care clinical practice, the character and
incidence of myocardial dysfunction in septic shock has
been studied further. Systolic as well as diastolic dysfunc-
tion, or a combination of the two, has been described, but
the true characteristics of this particular septic organ
failure remain unclear. Moreover, there is still lack of* Correspondence: lina.de.geer@regionostergotland.se
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entity. Numerous studies have investigated the prognostic
importance of myocardial depression in septic shock and
its impact on mortality, with conflicting results [3-6].
Echocardiographic measurement of systolic function
by assessing left ventricular ejection fraction (LVEF) is
dependent on volume and pressure load on the myocar-
dium, and the systolic function may be overestimated in
cases of severe septic vasodilatation [7]. The accuracy of
echocardiographic measurements of diastolic dysfunc-
tion by Doppler measurements of blood or tissue vel-
ocity is dependent on the ultrasonic angle towards the
tissue. Furthermore, mechanical ventilation, vasopressor
use and vasoplegia, all of which are common in septic shock
patients, pose challenges to a correct echocardiographicl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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raphy, an echocardiographic method measuring global
left-ventricular longitudinal myocardial deformation
(global longitudinal peak strain, GLPS), has been intro-
duced. This method has been claimed to be less pressure-
and angle-dependent and in cardiology settings has been
shown to be more sensitive in detecting cardiac dysfunction
than conventional echocardiography [9]. In a paediatric
population with septic shock, early myocardial dysfunction
was identified with strain echocardiography [10], and in a
recent experimental study in porcine septic shock, strain
echocardiography revealed myocardial dysfunction before
significant changes in LVEF were seen [11]. Furthermore, a
recent clinical study in severe sepsis and septic shock
patients has shown similar results with a higher preva-
lence of impaired GLPS than LVEF [12].
With the high mortality in septic shock, the recognition
of complicating factors, in this case myocardial dysfunc-
tion, is paramount. However, the role of strain echocardi-
ography in septic shock patients is not yet established.
The aim of this study was therefore to evaluate strain
echocardiography as a diagnostic and prognostic tool in
septic shock by examining its relationship to other com-
monly used left ventricular function parameters, to cardiac
biomarkers and clinical parameters, its change over time
and its relation to outcome. We hypothesize that strain
echocardiography can be used as a sensitive tool in the
early recognition of septic cardiac dysfunction.
Materials and methods
This study was approved by the Regional Ethical Review
Board in Linköping, Sweden (Dnr 2012/233-31). When
possible, informed consent was sought from patients at
inclusion. Due to the observational nature of the study
we were permitted to assume consent in patients who
because of acute illness were unable to give informed
consent. In these cases, informed consent was obtained
as soon as possible after recovery.
Patients aged 18 years or older, admitted to the mixed
non-cardiothoracic ICU of Linköping University Hos-
pital, presenting with septic shock and with an expected
ICU stay of 24 hours or longer, were screened for eligi-
bility. In total, 50 patients were included from October
2012 to September 2014. Patients could be included only
once. Patients who were not expected to survive longer
than 24 hours according to the treating physician, pa-
tients in whom intensive care treatment was partly with-
held from admission, and patients who due to language
barriers or mental inability were not expected to be able
to give consent even after recovery, were excluded. The
study period was from ICU admission and up to 7 days,
but shorter in cases of ICU discharge or death.
Septic shock was defined in the presence of the follow-
ing international criteria [13]: (1) evidence or clinicalsuspicion of infection; (2) two or more of the following
signs of systemic inflammatory response syndrome: (a)
temperature >38 or <36°C, (b) pulse >90 bpm, (c) respira-
tory rate >20 breaths/minute or mechanical ventilation,
and (d) white blood cells >12,000 μL−1 or <4,000 μL−1
or >10% bands; (3) at least one organ dysfunction; and (4)
systolic BP <90 despite fluid therapy and requiring vaso-
pressor therapy. All patients were treated according to
international guidelines for the treatment of septic shock
[13], and after initial resuscitation, at the discretion of the
treating clinician. Standard echocardiographic and labora-
tory results were not concealed to treating physicians, but
were not goals to which therapy was titrated. Patients
were considered to have a history of cardiac disease if they
had prior or current ischaemic heart disease, cardiac sur-
gery, hypertension or cardiac failure.
Transthoracic echocardiography was performed as
early as possible on the day of admission, and again after
initial resuscitation, on day 3 or 4. In survivors, a follow-
up echocardiogram was performed 8 to 30 days after in-
clusion. All echocardiograms were performed by an expert
echocardiographer not involved in patient care (JE), using
a Vivid E9 ultrasound scanner, acquiring two-dimensional
apical two-chamber, four-chamber and long-axis views
(2C, 4C and ALAX) with focus on the left ventricle (LV)
and at a frame rate of >40 frames/s. Images were analysed
offline using dedicated software (EchoPac version 112, GE
Ultrasound, Horten, Norway), all by one observer (LDG).
GLPS was calculated as the average speckle tracking strain
from each of the 18 LV segments from the 2C, 4C and
ALAX views (six segments per view, base-mid-apex, in
three views). LV volumes and (LVEF were calculated using
the modified biplanar Simpson method. E- and A-
velocities and E-deceleration time were measured using
pulsed wave (PW) Doppler in the mitral inflow at the tip
of the valve. Diastolic tissue velocity of the base of the LV
septum (é) was measured in the apical 4C view using PW
tissue Doppler, and E/é ratios were calculated. All echo-
cardiographic studies were recorded over three consecu-
tive cardiac cycles, independently of breathing cycles, and
averaged. Measurements were collected and averaged over
5 to 10 heartbeats in patients with non-sinus rhythm. To
assess interobserver variability, all images were also inde-
pendently analysed by an expert echocardiographer (JE).
GLPS was considered decreased when > −15% [14]. Sys-
tolic dysfunction was defined as LVEF <50% [15], and dia-
stolic dysfunction as E/é >15 and/or é <0.08 m/s [16].
Plasma concentrations of NT-proBNP and high-sensitivity
Troponin T were analysed daily during the study period,
the first sample being obtained as early as possible after
ICU admission, using a Cobas® e 411 (Roche Diagnostics,
Mannheim, Germany).
In patients where invasive continuous haemodynamic
monitoring by means of thermodilutional technique was
Table 1 Baseline characteristics of studied patients on day 1
Demographics
Patients, n 50
Sex, male, n (%) 31 (64)
Age, years, median (IQR) 65 (58 to 74)
Weight, kg, median (IQR) 71 (65 to 82)
Cardiac comorbidities, n (%) 24 (48)
Clinical data
SAPS 3, median (IQR) 73 (45 to 84)
SOFA day 1, median (IQR) 11 (9 to 12)
Mechanical ventilation, n (%) 39 (78)
Mechanical ventilation, hours, median (IQR) 67 (3 to 240)
Time in shock, hrs, median (IQR) 13 (8 to 22)
CRRT during ICU stay, n (%) 13 (26)
ICU length of stay, days, median (IQR) 5 (2 to 11)
Mortality
Death in ICU, n (%) 13 (27)
Death within 30 days, n (%) 15 (30)
Death within 90 days, n (%) 17 (34)
Data are presented as medians (lower quartile to upper quartile) and number (n)
of patients (%), as appropriate. SAPS, simplified acute physiology score; SOFA,
sequential organ failure assessment; CRRT, continuous renal replacement therapy.
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mercially available PiCCO® system (Pulsion Medical,
Munich, Germany) was used. The system was calibrated
at least thrice daily, and cardiac index (CI) and systemic
vascular resistance index (SVRI) from continuous mea-
surements were collected when echocardiography was
performed.
Clinical data on comorbidities, ventilator mode and
settings, heart rate and rhythm, arterial blood pressure,
fluid balance, vasopressor and inotropic infusion rates,
ICU length of stay and outcome, were all collected pro-
spectively. To assess severity of illness, the simplified acute
physiology score 3 (SAPS 3) [17] was calculated on admis-
sion, and the sequential organ failure assessment (SOFA)
score [18] was calculated daily.
Statistical analysis
Data are presented as median (lower quartile to upper
quartile) and number (percentage), as appropriate. For
comparison between groups, the Mann-Whitney U-test
and chi-square (χ2) test was used for continuous and
dichotomous variables, respectively. The correlation
between variables was explored using Spearman’s rank
correlation test, and for temporal changes, repeated-mea-
sures analysis of variance (ANOVA) was applied. Univari-
ate linear regression analysis was used to explore the
explanatory value of variables, and a logistic regression
model was calculated to determine the ability of variables
to predict mortality. Interobserver variability of echocar-
diographic parameters was determined by the intraclass
correlation coefficient. All probability values are two-
tailed and significance was set at P <0.05. All statistical
analyses were performed using IBM SPSS v22.0 (IBM
Corp, Armonk, NY, USA) and STATA v11.1 (Stata Corp
LP, College Station, TX, USA).
Results
This study included 50 patients in septic shock, who all
fulfilled the inclusion criteria of the study on admission.
Table 1 summarizes the main clinical characteristics of
included patients. The source of sepsis was pulmonary
in 17 patients (34%), gastrointestinal in 11 patients (22%)
and genitourinary in 11 patients (22%), and 7 patients
(14%) were neutropenic, with haematological malignan-
cies. Blood cultures were positive in 24 patients (48%), and
all patients were treated with antibiotics chosen by an
infectious disease specialist.
The first echocardiographic examination was performed
as early as possible after ICU admission, and always on
day 1. Two patients died before the echocardiogram was
performed, in three patients image quality was inadequate,
and in one patient, images were lost in the storage
process. Thus, in 44 patients (88%), echocardiographic
images could be analysed. On average, strain could bemeasured in 17 of the 18 LV segments. Of the 44 pa-
tients in whom echocardiography was performed after
admission and where images were suitable for ana-
lysis, 37 patients (84%) were tracheally intubated and
mechanically ventilated at the time of the examin-
ation. In survivors not yet discharged from the ICU,
in total 26 patients, a second echocardiogram was
performed after initial stabilisation (median 57 hours,
IQR 48 to 82 hours after the first echocardiogram).
In eight survivors who had not been transferred to re-
ferral hospitals, a follow-up echocardiogram was perfor-
med after discharge, 8 to 30 days after ICU admission and
inclusion.
Overall 31 patients (70%) had LV dysfunction at the
first examination. Decreased GLPS was seen in 18 pa-
tients (41%), whereas decreased LVEF was present in 22
patients (50%). Signs of diastolic dysfunction with de-
creased é velocity or increased E/é ratio were present in
18 patients (41%). As shown in Figure 1, there was
marked overlap between groups, with 15 patients (34%)
having decreased GLPS as well as decreased LVEF and/
or diastolic dysfunction. Of those examined a second
time, that is, alive but not yet discharged, there was LV
dysfunction in 16 patients (62%), all of whom had de-
creased GLPS in combination with other echocardio-
graphic signs of myocardial dysfunction.
Table 2 shows the strong correlation of GLPS to LVEF,
é, NT-proBNP and cardiac index on day 1. On the second
echocardiogram, performed after initial stabilisation, and
Figure 1 Clinical spectrum and distribution of myocardial
dysfunction on day 1 in studied patients. Data are presented as
number (percentage). LVEF, left ventricular ejection fraction; global
longitudinal peak strain; é, early mitral tissue Doppler velocity; E/é,
ratio of early mitral inflow (E) to é.
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GLPS did not at any time correlate to SVRI or vasopressor
dose, as measures of afterload, neither did it correlate to
respiratory pressures, volume load or fluid balance, nor to
SOFA score. Figure 2 shows the explanatory value of
GLPS on echocardiographic parameters and NT-proBNP
in a linear regression model. GLPS provided no explana-
tory value on clinical parameters.
Figure 3 shows the change in GLPS, LVEF, é and E/é
over time during the study period. All echocardiographic
parameters showed a large dispersion from day 1 to fol-
low up. LVEF and é showed significant change over time,
whereas GLPS and E/é did not. The day-to-day course
of laboratory and clinical parameters, with SOFA
score, NT-proBNP, volume load administered and positiveTable 2 Correlation of global longitudinal peak strain to left
biomarkers and haemodynamics
Global longitudinal peak st
Echocardiography on day 1
Echocardiographic parameters r P
Left ventricular ejection fraction, % −0.70 <0.001
Early mitral tissue Doppler velocity, cm/s −0.59 <0.001
Ratio of early mitral inflow to early
mitral tissue Doppler velocity
0.27 0.01
Cardiac biomarkers and data from invasive monitoring
Amino-terminal pro-brain natriuretic peptide 0.54 <0.001
High sensitivity troponin T 0.35 0.02
Cardiac index at time of echo −0.45 0.03end-expiratory pressure PEEP all showing significant
changes over time are presented in Figure 4.
Of the 50 patients included, 13 patients (26%) died in
the ICU. Another two patients died within 30 days, and
17 patients (34%) had died within 90 days. Table 3 sum-
marizes the main clinical, laboratory and echocardio-
graphic characteristics in survivors and non-survivors at
30 and 90 days, with a significant difference between
groups in SAPS 3, age, ICU length of stay and NT-
proBNP on admission. GLPS was the only echocar-
diographic parameter with a tendency to differ between
survivors and non-survivors. A logistic regression model
showed that GLPS >−15 gave a hazards ratio for death at
90 days of 2.5, but the result was not statistically signi-
ficant (95% CI 0.66, 9.46), and no predictive value was
gained by using a multivariable model with LVEF, é and
NT-proBNP in addition to global strain. The intraclass
correlation coefficient analysing interobserver variability
of GLPS was 0.92 (P <0.001).
Discussion
In this study we evaluate strain echocardiography for de-
tecting LV dysfunction in patients with septic shock.
The study demonstrates that GLPS is frequently im-
paired in septic shock patients irrespective of survival,
and that GLPS correlates with other echocardiographic
and laboratory signs of cardiac dysfunction. Further-
more, the study suggests that GLPS remains unchanged
over time, in spite of normalizing systolic function pa-
rameters, cardiac biomarkers, and clinical recovery.
The landmark study first describing cardiac dysfunc-
tion in septic shock showed systolic impairment in 10 of
20 patients during the first 48 hours [1]. Later studies
have reported similar results with a reduced global sys-
tolic function in 30 to 60% of septic shock patients
[5,19], and reversibility in those who survived [8,20,21].
The definition of systolic dysfunction has varied among
previous studies (LVEF <50 to 55%), which may in partventricular systolic and diastolic parameters, cardiac
rain
Echocardiography on day 3 to 4 Follow-up echocardiography
r P r p
−0.44 0.03 0.44 0.49
−0.39 0.06 0.12 0.77




Figure 2 Association of echocardiographic and laboratory markers of myocardial dysfunction. The regression lines between global
longitudinal peak strain and left ventricular ejection fraction, mitral annular motion velocity (é) and amino-terminal pro-brain natriuretic peptide
(NT-proBNP) on day 1.
Figure 3 Echocardiographic characteristics over time in studied patients. The dispersion (minimum, 25th percentile, median, 75th percentile,
maximum) and change over time of global longitudinal peak strain, left ventricular ejection fraction, mitral annular motion velocity (é) and early mitral
inflow to mitral annular motion velocity ratio (E/é) at echocardiogram on day 1, after stabilization and on follow up, and their change over time.
ANOVA, analysis of variance.
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Figure 4 Clinical characteristics over time in studied patients. The dispersion (minimum, 25th percentile, median, 75th percentile, maximum)
and change over time of sequential organ failure assessment (SOFA) score, amino-terminal pro-brain natriuretic peptide (NT-proBNP), the total
volume of fluids administered and the peak positive end-expiratory pressure (PEEP) in studied patients on each day during the study period.
ANOVA, analysis of variance.
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are in line with these previous results, with reduced
LVEF in 50% of patients and improvement in survivors.
In recent years, especially since the introduction of tis-
sue Doppler in intensive care practice, diastolic dysfunc-
tion in septic shock has gained interest. Several studies
have shown decreased é and increased E/é in this set-
ting, with a prevalence of 20 to 57% [3,4,21-23]. Differ-
ences in study size and characteristics in previous
cardiac disease and clinical circumstances may have
contributed to these differences. When using the same
definition of diastolic dysfunction as in these studies
(E/é >15 or é <0.08 m/s) we found a prevalence of 50%.
In contrast to previous longitudinal studies, no improve-
ment over time was seen [3,4,21,22].
The impact of myocardial dysfunction on mortality in
septic shock is still unclear. When first described, LVEF
was paradoxically reduced in survivors compared with
non-survivors [1]. Later studies have confirmed this
finding [6], whereas in other studies, and in ours, no dif-
ference in LVEF between survivors and non-survivors
has been detected [5,23]. This may be related to the small
sample size (n = 21 to 61) or to the large prevalence ofpre-existing cardiac disease (43 to 59%) in these studies as
well as in ours, but the finding has been confirmed by
other, larger studies (n = 106 to 262) [3,4]. In contrast, a
substantial impact of diastolic dysfunction on mortality in
septic shock has been shown [23]. Larger studies have
confirmed this finding, but have included patients with
severe sepsis alongside those with septic shock, which
complicates direct comparison with our study [3,4], where
we saw no difference in systolic or diastolic parameters
between survivors and non-survivors. GLPS was the only
echocardiographic parameter that had a tendency to differ
between survivors and non-survivors, but neither of the
parameters could be used in a prognostic model. However,
this is in line with two previous studies evaluating GLPS
in sepsis [10,12].
In order to further characterize the nature of cardiac
dysfunction in septic shock, other echocardiographic
techniques have been used to investigate the systolic and
diastolic function in sepsis. Tissue Doppler measures of
the peak systolic velocity at the mitral annulus (Sa) in
septic shock have shown a linear association with LVEF
[5,24], and the association of Sa to mortality has been
stronger than that of LVEF. Mitral annular plane systolic
Table 3 Patient characteristics on ICU admission (day 1) in comparison between survivors and non-survivors
30 Days P 90 Days P
Survivors, n = 35 Non-survivors, n = 15 Survivors, n = 33 Non-survivors, n = 17
Demographics
Male sex, n (%) 24 (69) 7 (47) 0.12 18 (55) 9 (53) 0.54
Age, years, median (IQR) 65 (56 to 71) 75 (65 to 79) 0.01 64 (54 to 71) 72 (65 to 79) 0.02
Weight, kg, median (IQR) 74 (65 to 85) 68 (64 to 80) 0.42 72 (63 to 84) 70 (64 to 81) 0.86
Cardiac comorbidities, n (%) 15 (43) 9 (60) 0.23 14 (42) 10 (59) 0.17
Clinical data and cardiac biomarkers
Saps 3, median (IQR) 70 (59 to 76) 81 (70 to 88) 0.03 68 (59 to 76) 81 (70 to 88) 0.01
ICU length of stay, days, median (IQR) 115 (56 to 272) 93 (23 to 142) 0.13 168 (81 to 290) 78 (23 to 143) 0.02
Mechanical ventiltion, hours,
median (IQR)
70 (0 to 240) 45 (9 to 135) 0.77 154 (19 to 245) 40 (2 to 118) 0.17
Sequential organ failure
assessment score
10 (9 to 12) 12 (9 to 14) 0.62 10 (9 to 12) 11 (9 to 14) 0.61
PEEP, cmH2O 14 (10 to 16) 12 (10 to 15) 0.73 12 (10 to 15) 12 (10 to 15) 0.91
Pmax, cmH2O 28 (22 to 31) 32 (26 to 34) 0.18 28 (21 to 31) 32 (26 to 34) 0.21
Norepinephrine, ug/kg/min 0.09 (0.05 to 0.14) 0.11 (0.05 to 0.26) 0.50 0.09 (0.06 to 0.16) 0.08 (0.04 to 0.22) 0.95
Dobutamine, ug/kg/min 5.5 (3.1 to 8.2) 5.4 (4.7 to 11.3) 0.46 5.1 (3.1 to 8.8) 5.6 (4.8 to 10.4) 0.34
Fluids administered, ml/kg 127 (100 to 154) 89 (60 to 200) 0.34 131 (100 to 154) 90 (62 to 118) 0.15
Fluid balance, ml/kg 70 (33 to 95) 21 to 151) 0.99 71 (31 to 104) 59 (23 to 132) 0.96
Cardiac index, l/min/ m2 4.0 (3.3 to 5.0) 5.0 (4.6 to 5.4) 0.14 4.0 (3.2 to 5.1) 4.9 (4.3 to 5.4) 0.16
SVRI dyn × sec × cm−5/m2 1310 (1066 to 1582) 800 (600 to 852) 0.001 1,310 (1,062 to 1,585) 801 (600 to 1045) 0.002
NT-proBNP, ng/L 4230 (1410 to 10400) 7940 (2780 to 26400) 0.15 4,070 (1,400 to 8,510) 10,500 (2,860 to 30,700) 0.03
High sensitivity troponin T, ng/L 40 (24 to 119) 121 (39 to 530) 0.09 40 (26 to 236) 115 (42 to 348) 0.08
Echocardiography
Global longitudinal peak strain, % −17.2 (−20.0 to (−13.0)) −15.0 (−19.7 to (−11.0)) 0.34 −17.4 (−20.5 to −13.6) −14.7 (−19.0 to −10.6) 0.11
Left ventricular ejection fraction, % 50 (42 to 57) 53 (37 to 59) 0.99 50 (44 to 58) 47 (36 to 56) 0.47
E/é 7.1 (5.9 to 11.0) 7.7 (5.4 to 10.7) 0.62 7.4 (6.0 to 11.7) 7.4 (5.7 to 9.0) 0.60
é, m/s 0.11 (0.08 to 0.18) 0.12 (0.83 to 0.16) 0.99 0.11 (0.08 to 0.16) 0.11 (0.08 to 0.16) 0.95
E, m/s 0.97 (0.79 to 1.07) 0.95 (0.61 to 1.07) 0.53 0.98 (0.79 to 1.08) 0.95 (0.60 to 1.11) 0.46
A, m/s 0.73 (0.57 to 0.92) 0.99 (0.845 to 1.20) 0.31 0.73 (0.59 to 0.89) 0.81 (0.47 to 1.48) 0.34
E/A 1.2 (1.0 to 1.7) 1.0 (0.8 to 1.2) 0.10 1.2 (1.0 to 1.7) 1.1 (0.9 to 1.2) 0.60
DT, ms 157 (140 to 197) 171 (105 to 200) 0.97 156 (140 to 199) 172 (126 to 204) 0.93
Data are presented as median (IQR) or number (%), as appropriate. SAPS, simplified acute physiology score; Pmax, peak inspiratory pressure; PEEP, positive end-
expiratory pressure; SVRI, systemic vascular resistance index; NT-proBNP, amino-terminal pro-brain natriuretic peptide; E: early mitral inflow; é: early mitral tissue
Doppler velocity; A: late mitral inflow; DT: early mitral inflow deceleration time.
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LVEF as well as to E/é and é [25], and therefore is
assumed to reflect systolic as well as diastolic func-
tion. Strain echocardiography, used in this study, de-
scribes tissue deformation, and GLPS is viewed as a
measure of systolic function representing contractility.
However, we demonstrated here the association of
GLPS not only to LVEF but also to é, E/é and to NT-
proBNP and cardiac index, and also a marked overlap
of, or interaction between, systolic and diastolic
dysfunction. Thus, while GLPS seems to reflect the
systolic dysfunction, systolic dysfunction commonlycoincides with diastolic dysfunction in patients with
septic shock.
In a recent study on severe sepsis and septic shock
patients, there was a higher prevalence of impaired
GLPS than of reduced LVEF [12]. In contrast, we found
reduced LVEF to be more frequent than reduced GLPS,
although direct comparison between the two studies is
complicated by differences in inclusion criteria, with all
our patients being in septic shock. Also, our findings
suggest that GLPS is relatively independent of SVRI,
vasopressor and inotropes, volume loading and extrinsic
ventilator pressure, all of which most certainly affect
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of a recent experimental study, where GLPS decreased
in correlation with LVEF, but earlier in the course of
septic shock, and was impaired in spite of a decreased
SVRI [11]. GLPS has indeed been claimed to be rela-
tively independent of pre-load and after-load, in addition
to being less angle-dependent than tissue Doppler ultra-
sound [9]. Furthermore, we saw a significant improve-
ment over time in systolic parameters as well as in
clinical conditions over time, but no change in GLPS.
This might indicate that a decreased GLPS could repre-
sent more subtle changes in the myocardium in septic
shock that persist even after clinical recovery. In cardio-
logical studies, GLPS has been sensitive in detecting myo-
cardial disease such as hypertrophic cardiomyopathy [26],
cardiac amyloidosis [27] and chemotherapy-associated
cardiac dysfunction, even in asymptomatic patients [28].
Further studies are needed to investigate the importance,
the time course and the long-term nature of decreased
GLPS in septic shock patients.
Limitations
This is a single-centre study, and local management
strategies may have influenced patient selection as well
as treatment and outcome. Our hospital is a tertiary care
centre to which some patients are referred from other
hospitals, where sepsis treatment may have started before
admission. In addition, patient selection may have been
biased by the strict exclusion criteria of the study,
with the most severely ill patients not being included.
Second, the clinical spectrum of septic shock is wide
and highly dynamic, and although all patients were in-
cluded during the first 24 hours after ICU admission,
time from initial presentation of disease to echocardiogram
and other measurements varies. Also, the study would have
been strengthened if echocardiography had been performed
daily during the study period. Furthermore, treating physi-
cians were not blinded to measurements or results, which
may have influenced the treatment of patients. Still, our
intention was not to study differences in treatment, and
the clinician’s treatment decisions should always be based
on all available data. Finally, the group of studied patients
is small, and cannot be expected to provide definite con-
clusions about outcome.
The strength of the study lies in the parallel use of
echocardiographic measurements, biomarkers and clin-
ical data analysed repeatedly throughout the most un-
stable period. Further strength lies in survivors being
followed up to investigate the normalization over time
of myocardial dysfunction in sepsis, as described by
others. Moreover, as strain echocardiography represents
a computer-generated measurement, it is potentially
more objective and possibly less user-dependent, than
other echocardiographic measurements.Conclusion
We conclude that GLPS is frequently reduced in intensive
care patients with septic shock, survivors as well as non-
survivors. The impairment of GLPS correlates to that of
systolic as well as diastolic LV function parameters and
cardiac biomarkers, but remains unchanged over time,
even after clinical recovery. The study provides additional
insights into the pathophysiology of septic myocardial de-
pression, and together with further studies the results may
question the accepted view on septic cardiac depression as
a septic organ failure that resolves with clinical recovery.
Key messages
 Strain echocardiography can be used to show
LV dysfunction in septic shock
 GLPS correlates with other echocardiographic and
laboratory markers of myocardial dysfunction
 GLPS is frequently impaired in survivors as well as
non-survivors of septic shock
 GLPS remains unchanged in contrast to
normalizing systolic function parameters and
biochemical markers
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